Dermatological Complications of Diabetes Mellitus; Allergy to Insulin and Oral Agents

  • Ellen S. Marmur
  • Fiona R. Pasternack
  • Matthew C. Varghese

Abstract

Longstanding diabetes and/or lack of “tight glucose control” over time may result in the development of complications affecting many organ systems, including the skin. In many patients, the first presentation of diabetes may be in the form of dermatitis. Therefore, recognition of skin manifestations of diabetes mellitus is an important aspect of the physical examination. Most cutaneous manifestations of diabetes are attributed either to chronic degenerative changes or to metabolic derangement.

Keywords

Diabetic Neuropathy Lichen Planus Cutaneous Manifestation Acanthosis Nigricans Tight Glucose Control 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Perez MI, Kohn SR. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 30: 519–31, 1994.PubMedCrossRefGoogle Scholar
  2. 2.
    Krakowski A, Covo J, Berlin C. Diabetic scleroderma. Dermatologica, 146: 193–8, 1973.PubMedCrossRefGoogle Scholar
  3. 3.
    Rosenbloom AL, Silverstein JM, Lezotte DC, et al. Limited joint mobility in childhood diabetes mellitus indicates increased risk of microvascular disease. N Engl J Med 305: 191–4, 1981.PubMedCrossRefGoogle Scholar
  4. 4.
    Meure M, Szeimies RM. Diabetes mellitus and skin diseases. Curr Probl Dermatol 20: 11–23, 1991.Google Scholar
  5. 5.
    Braverman IM, Ed. Skin signs of systemic disease. WB Saunders, Philadelphia, PA, 654–64, 1981.Google Scholar
  6. 6.
    Huntley AC. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 7: 427–55, 1982.PubMedCrossRefGoogle Scholar
  7. 7.
    Quimby SR, Muller SA, Schroeter AL. The cutaneous immunopathology of necrobiosis lipodica diabeticorum. Arch Dermatol 124: 1364–71, 1998.CrossRefGoogle Scholar
  8. 8.
    Karkavitsas K, et al. Aspirin in the management of necrobiosis lipodica. Acta Derm 62: 183, 1982.Google Scholar
  9. 9.
    Freinkel RK. Diabetes mellitus In Fitzpatrick’s Dermatology in General Medicine, 5t Edition. Mc-Graw Hill, New York, p. 1969, 1999.Google Scholar
  10. 10.
    Dicken CH, Carrington SG, Winkelmann RK. Generalized granuloma annulare. Arch Dermatol 99: 556–63, 1969.PubMedCrossRefGoogle Scholar
  11. 11.
    Dabski K, Winkelmann RK. Generalized granuloma annulare: clinical and laboratory findings in 100 patients. J Am Acad Dermatol 20: 39–47, 1989.PubMedCrossRefGoogle Scholar
  12. 12.
    Muhlemann MF, Williams DR Localized granuloma annulare is associated with insulin-dependent diabetes. Br J Dermatol 111: 325–9, 1984.PubMedCrossRefGoogle Scholar
  13. 13.
    Thyresson HN, Doyle JA, Winkelmann RK. Granuloma annulare: histopathologic and direct immunofluorescence study. Acta Denn Venereol (Stockh) 60: 261, 1980.Google Scholar
  14. 14.
    Sherry DD, Rothstein RR, Petty RE, et al. Joint contracture preceding insulin-dependent diabetes mellitus. Arthritis Rheum 25: 1362–4, 1982.PubMedCrossRefGoogle Scholar
  15. 15.
    Starkman HS, Gleason RE, Rand LI, et al. Limited joint mobility of the hands in patients with diabetes mellitus. Ann Rheum Dis 45: 130–5, 1986.PubMedCrossRefGoogle Scholar
  16. 16.
    Lieberman LS, Rosenbloom AC, Riley WJ, et al. Reduced skin thickness with pump administration of insulin. N Engl J Med 303: 940–1, 1980.PubMedGoogle Scholar
  17. 17.
    Weissman K. Skin disorders in diabetes mellitus In Rook/Wilkinson/Ebling’s Textbook of Dermatology. Blackwell Science, Inc: Malden, MA, p. 2676, 1998.Google Scholar
  18. 18.
    Brik R, Berant M, Vardi P. The Sclerodenna-Like Syndrome of Insulin Dependent Diabetes Mellitus. Diabetes-Metabolism Reviews 7 (2): 120–8, 1991.PubMedGoogle Scholar
  19. 19.
    Sabin JA. Bacterial infections in diabetes mellitus. Br J Dennatol 91: 481, 1974.Google Scholar
  20. 20.
    Meurer M, Szeimies RM. Diabetes mellitus and skin diseases. Curr Probl Dermatol 20: 11–23, 1991.PubMedGoogle Scholar
  21. 21.
    Knight L, Fletcher J. Growth of candida albicans in saliva: stimulation by glucose associated with antibiotics, corticosteroids and diabetes mellitus. J Infect Dis 123: 371–7, 1971.PubMedCrossRefGoogle Scholar
  22. 22.
    Oakley WG, Pyke DA, Taylor KW, ed.. Diabetes and its management. Oxford, Blackwell Scientific Publications, Oxford, UK, p.43, 1978.Google Scholar
  23. 23.
    Calhoun JH, Mader JT. Infection in the diabetic foot. Hosp Pract 30: 81–104, 1992.Google Scholar
  24. 24.
    Zaky DA, Bentley DW, Lowy K, Betts RF, Douglas RG. Malignant external otitis: a severe form of otitis in diabetic patients. Am J Med 61: 298–302, 1976.PubMedCrossRefGoogle Scholar
  25. 25.
    Montes LF, Dobson H, Dodge BG, Knowles WR. Erythrasma and diabetes mellitus. Arch dennatol 99: 674–680, 1969.Google Scholar
  26. 26.
    Tomford JW, Whittlesey D, Ellner JJ, Tomashefski JF. Invasive primary cutaneous phycomycosis in diabetic leg ulcers. Arch Surg 115: 770–771, 1980.PubMedCrossRefGoogle Scholar
  27. 27.
    Alteras I, Saryt E. Prevalence of pathogenic fungi in the toe-webs and toe-nails of diabetic patients. Mycopathologia 67: 157–159, 1979.PubMedCrossRefGoogle Scholar
  28. 28.
    Lugo-Somolinos A, Sanchez JL. Prevalence of dermatophytosis in patients with diabetes. J Am Acad Dermatol 26: 408–10, 1991.CrossRefGoogle Scholar
  29. 29.
    Basarab T, Munn SE, McGrath J, Jones RR. Bullous diabeticorum: a case report and literature review. Clin Exp Dermatol 20: 218–20 1995.PubMedCrossRefGoogle Scholar
  30. 30.
    Bernstein JE, Medenica M, Soltani K, et al. Bullous eruption of diabetes mellitus. Arch Dermatol 115: 324–5, 1975.CrossRefGoogle Scholar
  31. 31.
    Bernstein JE, Levine LE, Medenica MM, et al. Reduced threshold to suction-induced blister formation in insulin-epidermolysis bullosa without immunoreactants. J Am Acad Dermatol 8: 790–1, 1983.PubMedCrossRefGoogle Scholar
  32. 32.
    Gilchrest B, Rowe JW, Mihm MC. Bullous dermatosis of hemodialysis. Ann Intern Med 83: 480–3, 1975.PubMedCrossRefGoogle Scholar
  33. 33.
    Glynne P et al. Bullous dermatoses in end-stage renal failure: porphyria or pseudoporphyria? Amer J Kidney Diseases 34: 155–60, 1999.CrossRefGoogle Scholar
  34. 34.
    Vadoud-Sayedi et al. Treatment of hemodialysis-associated pseudoporphyria with N-acetylcysteine: report of two cases. Br J Dermatol 142: 580–1, 2000.CrossRefGoogle Scholar
  35. 35.
    Rendon MI, Ponciano PD, Sontheimer RD et al. Acanthosis nigricans: a cutaneous marker of tissue resistance to insulin. J Am Acad Dermatol 21: 461–9, 1989.PubMedCrossRefGoogle Scholar
  36. 36.
    Sibbald RG, Schachter RK. The skin and diabetes mellitus. Int J Dermatol, 23: 567–584, 1984.PubMedCrossRefGoogle Scholar
  37. 37.
    Podolsky S. Lipoatrophic diabetes and leprechaunism, in Podolsky S, Viswanthan M, Eds. The Spectrum of the diabetic syndromes. New York, Raven Press, pp. 335–352, 1980.Google Scholar
  38. 38.
    Louis LH, Conn VW, Minick MC. Lipoatrophic diabetes: isolation and characterization of insulin anatagonist from the urine. Metabolism 12: 867–886, 1963.PubMedGoogle Scholar
  39. 39.
    Lawrence RD. Lipodystrophy and hepatomegaly with diabetes, lipemia, and other metabolic disturbances. Lancet 250: 724–731, 1946.CrossRefGoogle Scholar
  40. 40.
    Dunnigan MG. Unusual clinical manifestations of diabetes mellitus. Practitioner 222: 321–330, 1979.PubMedGoogle Scholar
  41. 41.
    Mabry CC, Hollingsworth DR, Upton CV and Corbin A. Pituitary-hypothalamic dysfunction in generalized lipodystrophy. J Pediatrics 82 (4): 625–33, 1973.CrossRefGoogle Scholar
  42. 42.
    Oseid S, Beck-Nielsen H, Pederson O, Sovik O. Decreased binding of insulin to its receptor in patients with congenital generalized lipodystrophy. N Engl J Med 296: 245–248, 1977.PubMedCrossRefGoogle Scholar
  43. 43.
    Jelinek, JE. The skin in diabetes mellitus: cutaneous manifestations, complications and associations. In Yearbook of dermatology, 1970. Chicago, Year Book Medical Publishers, Inc., pp. 5–35, 1970.Google Scholar
  44. 44.
    Hoerer E, Dreyfuss F, Herzberg M. Carotenemia, skin color and diabetes mellitus. Acta Diabetol Lat 12: 202–7, 1975.PubMedCrossRefGoogle Scholar
  45. 45.
    Rapini RP, Herbert AA, Drucker CR. Acquired perforating dermatosis: evidence for combined transepidermal elimination of both collagen and elastic fibers. Arch Dermatol 125: 1074–8, 1989.PubMedCrossRefGoogle Scholar
  46. 46.
    Lithner F. Purpura, pigmentation and yellow nails of the lower extremities in diabetes. Acta Med Scand 199: 203–8, 1976.PubMedCrossRefGoogle Scholar
  47. 47.
    Halevy S, Feuerman EJ. Abnormal glucose tolerance associated with lichen planus. Acta Derm Venereol 59: 167–70, 1979.PubMedGoogle Scholar
  48. 48.
    Albrecht M, Banoczy J, Dinya E, et al. Occurrence of oral leukoplakia and lichen planus in diabetes mellitus. J Oral Pathol 21: 364–6, 1992.CrossRefGoogle Scholar
  49. 49.
    Muller SA. Dermatologic disorders associated with diabetes mellitus. Mayo Clin Proc 41: 689–703, 1966.PubMedGoogle Scholar
  50. 50.
    Pinkus H, Mehregan AH. A guide to dermatohistopathology. New York, Appleton-Century-Crofts, p. 417, 1976.Google Scholar
  51. 51.
    Chevrant-Breton J, Simon M, Bourel M, Ferrand B. Cutaneous manifestations of idiopathic hemochromatosis. Arch Dermatol 113: 161–5, 1977.PubMedCrossRefGoogle Scholar
  52. 52.
    Kahana M, Grossman E, Feinstein A, et al. Skin tags: a cutaneous marker for diabetes mellitus. Acta Derm Venereol 67: 175–7, 1986.Google Scholar
  53. 53.
    Bleich HL, Boro ES. Diabetic polyneuropathy: the importance of insulin deficiency, hyperglycemia and alterations in myoinositol metabolism in its pathogenesis. N Engl J Med 295: 1416–20, 1976.CrossRefGoogle Scholar
  54. 54.
    Levy DM, Teenghi G, GU XH. Immunohistochemical measurements of nerves and neuropeptides in diabetic skin: relationship to tests of neurological function. Diabetologia 35: 889–97, 1992.PubMedCrossRefGoogle Scholar
  55. 55.
    Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326: 1250–6, 1992.PubMedCrossRefGoogle Scholar
  56. 56.
    Ellenberg M. Diabetic Foot. NY State J Med, 73: 2778–2781, 1973.Google Scholar
  57. 57.
    Lippman HI, Perotto A, Farrar R. The neuropathic foot of the diabetic. Bull NY Acad Med 52: 1159–1178, 1976.Google Scholar
  58. 58.
    Editorial. Diabetic foot ulcers. Lancet 1: 232–233, 1977.Google Scholar
  59. 59.
    Ajam Z, Barton SP, Marks R. Characterization of abnormalities in the cutaneous microvasculature of diabetic subjects. Br J Dermatol 107 (suppl 22): 22–3, 1982.Google Scholar
  60. 60.
    Huntley AC. Cutaneous manifestations of diabetes mellitus. Dermatol Clin 7: 531–46, 1989.PubMedGoogle Scholar
  61. 61.
    Grunfeld C. Diabetic foot ulcers: etiology, treatment and prevention. Adv Intern Med 37: 103–32, 1991.Google Scholar
  62. 62.
    Ditzel J. Functional microangiopathy in diabetes mellitus. Diabetes 17: 388397, 1968.Google Scholar
  63. 63.
    Landau J, Davis E. The small blood vessels of the conjunctiva and nailbed in diabetes mellitus. Lancet 2: 731–734, 1960.PubMedCrossRefGoogle Scholar
  64. 64.
    Lithner F, Hietala SO. Skeletal lesions of the feet in diabetics and their relationship to cutaneous erythema with or without necrosis of the feet. Acta Med Scand 200: 155–161, 1976.PubMedCrossRefGoogle Scholar
  65. 65.
    Fitzpatrick TB et al. Color atlas and synopsis of clinical dermatology. New York, McGraw-Hill, pp. 417–8, 2001.Google Scholar
  66. 66.
    Feingold KR, Siperstein MD. Diabetic vascular disease. Adv Intern Med; 31: 309–40, 1986.PubMedGoogle Scholar
  67. 67.
    Haroon TS. Diabetes and skin: a review. Scott Med J 19: 257–67, 1974.PubMedGoogle Scholar
  68. 68.
    Jegasothy, BV. Allergic reactions to insulin. Int J Dermatol, 19: 139–41, 1980.PubMedCrossRefGoogle Scholar
  69. 69.
    Galloway JA, Davidson JK. Clinical use of insulin, in Rifkin H, Raskin P, Eds. Diabetes mellitus. Bowie, RJ Brady Co., vol 5, pp 117–27, 1981.Google Scholar
  70. 70.
    Feinglos MN, Jegasothy BV. “Insulin” allergy due to zinc. Lancet 1: 122–24, 1979.PubMedCrossRefGoogle Scholar
  71. 71.
    Galloway, JA, Bressler R. Insulin treatment in diabetes. Med Clin North Am 62: 663–80, 1978.PubMedGoogle Scholar
  72. 72.
    Grammer LC, Metzger BE, Patterson R. Cutaneous allergy to human (recombinant DNA) insulin. JAMA 251: 1459–60, 1984.PubMedCrossRefGoogle Scholar
  73. 73.
    Edidin DV. Cutaneous manifestations of diabetes mellitus in children. Pediatr Dermatol 2: 161–179, 1985.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • Ellen S. Marmur
  • Fiona R. Pasternack
  • Matthew C. Varghese

There are no affiliations available

Personalised recommendations